AI-Driven Discovery and Manufacturing Capacity: Antibodies Market Investment Focus
Antibodies Market Investment is significantly increasing, channeled into high-yield, transformative technologies: Advanced Manufacturing: Investment is pouring into establishing large-scale, dedicated manufacturing facilities, such as AstraZeneca's planned $1.5 billion facility in Singapore for Antibody-Drug Conjugates (ADCs), to secure the supply chain for next-generation products....
0 Reacties 0 aandelen 66 Views 0 voorbeeld